SK
Insider selling
Sanj K Patel sold $364K of Kiniksa Pharmaceuticals International, plc (KNSA) stock
Sanj K Patel, Chairman & CEO of Kiniksa Pharmaceuticals International, plc (KNSA), sold 7,278 shares of KNSA stock worth $364K, per an SEC Form 4 filed Apr 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 6, 2026, 2 days before it was made public.
KNSA has moved +57.7% since the trade date, from $49.55 to $78.13 (Sep 21, 2026 close).
- Traded
- Apr 6, 2026
- Disclosed
- Apr 8, 2026
- Filing delay
- 2 days
- Price since
- +57.7%
- Role
- Chairman & CEO
- Source
- SEC Form 4
More KNSA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.